Clinically Studied Strains

In human clinical trials, B. longum BB536, L. rhamnosus R0011 and L. helveticus R0052 were studied and found to interact with the intestinal tract and its environment in multiple ways. Research has demonstrated that these probiotic strains may bolster the gut microflora, bolster gut health, and bolster immunity.*